Handelsavisen
prelaunch
Companies Healthcare CHHB.KL
CH
CHHB.KL Bursa Malaysia Healthcare Facilities & Services

Chhb.Kl

$0,15
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-44,7 %
ROE
-7,1 %
Net margin
-60,8 %
Debt / equity
0,07
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

CHHB.KL operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.

Business. CHHB.KL operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-7,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CHHB.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CHHB.KL. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    CHHB.KL operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    CHHB.KL's capital structure is characterized by a low debt-to-equity ratio of 0.07, indicating a conservative approach to leverage. However, the company's liquidity is rated as medium, and its current ratio of 0.85 suggests that it may struggle to meet short-term obligations with its current assets. The company's operating cash flow is positive at MYR 1.23 million, but this is significantly lower than the capital expenditure of MYR 2.76 million, indicating a net outflow of cash from operations.

    In terms of profitability, CHHB.KL is currently unprofitable, with a net loss of MYR 41.89 million and an operating loss of MYR 30.82 million. The return on equity is -7.1%, and the return on assets is -4.36%, both of which are negative and suggest poor performance relative to its equity and asset base. These figures are likely below the industry median for healthcare facilities and services, indicating that the company is underperforming its peers in terms of profitability and returns.

    CHHB.KL's revenue is not segmented by geographic regions or business lines in the provided data, so it is not possible to determine the geographic exposure or revenue concentration. However, the lack of segmentation data suggests that the company may have a concentrated revenue base, which could pose a risk if a particular market or product line underperforms.

    The company's growth trajectory is not clearly defined in the provided data, as there are no specific numeric deltas or revenue history provided for the current or next fiscal year. The absence of growth data makes it difficult to assess the company's future performance or its ability to increase revenue and profitability.

    The risk assessment for CHHB.KL indicates a medium liquidity risk and a low dilution risk. The company has a key flag indicating that its net cash is negative after subtracting total debt, which could affect its ability to fund operations and investments. The dilution risk is low, suggesting that the company is not expected to issue additional shares in the near term, which could help maintain shareholder value.

    There are no recent events, such as filings or transcripts, provided in the data to indicate any significant changes in the company's operations or strategy. The absence of recent events suggests that the company may be in a stable but uneventful phase, with no major developments affecting its financial performance or market position.

    Key takeaways
    • CHHB.KL is currently unprofitable with a net loss of MYR 41.89 million and an operating loss of MYR 30.82 million.
    • The company has a low debt-to-equity ratio of 0.07, indicating a conservative capital structure.
    • CHHB.KL's liquidity is rated as medium, and its current ratio of 0.85 suggests potential difficulties in meeting short-term obligations.
    • The company's return on equity is -7.1%, and the return on assets is -4.36%, both of which are negative and indicate poor performance.
    • The company's net cash is negative after subtracting total debt, which could affect its ability to fund operations and investments.
    • margin_outlook_rationale: The company's current unprofitability and negative returns suggest a challenging margin outlook driven by operational inefficiencies and high costs.
    • rd_outlook_rationale: There is no specific information provided about the company's research and development activities or their expected impact on future performance.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,15
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $590.0M
    Net cash
    -$39.7M
    Current ratio
    0.8
    Debt / equity
    0.1
    ROA
    -4.4%
    ROE
    -7.1%
    Cash conversion
    -3.0%
    CapEx / revenue
    -4.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-44,7 %Bottom quartile
    Net Margin-60,8 %Bottom quartile
    ROE-7,1 %Bottom quartile
    Capex / Rev-4,0 %Above median
    D/E0,07Above P75
    Cash Conv-0,03Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • CHHB.KL Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CHHB.KLCanonical
    Bursa Malaysia · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage